Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457912 · ClinicalTrials.gov registry record
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
A clinical trial, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 277
- Enrollment target
NCT00457912: Completed study, sponsored by Nationwide Children's Hospital.
NCT00457912 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 277 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00457912 has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
Study Summary
The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this study, the investigators will perform a muscle biopsy and DNA testing in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will be extended to the family of the study subject in order to better understand true genetic defect.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2005-06 |
| Est. Completion | 2018-01-01 |
What the finished NCT00457912 record still lists
NCT00457912 is an observational study that tracks outcomes without assigning an intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00457912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00457912 about?
NCT00457912 is a clinical study titled "Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy". The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this stud...
What is the current status of trial NCT00457912?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2005-06. Estimated completion is 2018-01-01.
Who is sponsoring clinical trial NCT00457912?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05818683 · 277 participants · Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
- NCT06789913 · 277 participants · Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia